BioPorto A/S (THOXF)
USD 0.29
(0.0%)
USD 0.29
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.78 Million DKK | 48.05% |
| 2022 | 2.55 Million DKK | -5.89% |
| 2021 | 2.71 Million DKK | -14.12% |
| 2020 | 3.16 Million DKK | -23.83% |
| 2019 | 4.15 Million DKK | 14.43% |
| 2018 | 3.63 Million DKK | 5.74% |
| 2017 | 3.43 Million DKK | -12.86% |
| 2016 | 3.94 Million DKK | -2.31% |
| 2015 | 4.03 Million DKK | 0.75% |
| 2014 | 4 Million DKK | 10.33% |
| 2013 | 3.62 Million DKK | -14.17% |
| 2012 | 4.22 Million DKK | 15.58% |
| 2011 | 3.65 Million DKK | 6.55% |
| 2010 | 3.43 Million DKK | 4.16% |
| 2009 | 3.29 Million DKK | 5.34% |
| 2008 | 3.12 Million DKK | 0.0% |
| 2007 | - DKK | 0.0% |
| 2006 | - DKK | 0.0% |
| 2005 | - DKK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.27 Million DKK | -13.63% |
| 2024 Q2 | 4.29 Million DKK | 31.27% |
| 2023 Q1 | 2.37 Million DKK | -7.19% |
| 2023 Q2 | 1.75 Million DKK | -26.07% |
| 2023 Q4 | 3.78 Million DKK | 182.19% |
| 2023 Q3 | 1.34 Million DKK | -23.53% |
| 2023 FY | 3.78 Million DKK | 48.05% |
| 2022 Q3 | 3.2 Million DKK | 43.91% |
| 2022 Q4 | 2.55 Million DKK | -20.11% |
| 2022 Q1 | 2.22 Million DKK | -18.25% |
| 2022 Q2 | 2.22 Million DKK | 0.14% |
| 2022 FY | 2.55 Million DKK | -5.89% |
| 2021 FY | 2.71 Million DKK | -14.12% |
| 2021 Q1 | 2.62 Million DKK | -16.94% |
| 2021 Q3 | 3.86 Million DKK | 27.63% |
| 2021 Q4 | 2.71 Million DKK | -29.69% |
| 2021 Q2 | 3.02 Million DKK | 15.21% |
| 2020 Q3 | 3.75 Million DKK | -4.87% |
| 2020 Q1 | 3.75 Million DKK | -9.58% |
| 2020 FY | 3.16 Million DKK | -23.83% |
| 2020 Q4 | 3.16 Million DKK | -15.64% |
| 2020 Q2 | 3.94 Million DKK | 4.98% |
| 2019 Q1 | 3.67 Million DKK | 1.32% |
| 2019 FY | 4.15 Million DKK | 14.43% |
| 2019 Q2 | 3.73 Million DKK | 1.58% |
| 2019 Q4 | 4.15 Million DKK | 12.12% |
| 2019 Q3 | 3.7 Million DKK | -0.83% |
| 2018 Q3 | 3.36 Million DKK | -12.72% |
| 2018 Q2 | 3.85 Million DKK | 22.94% |
| 2018 Q1 | 3.13 Million DKK | -8.59% |
| 2018 FY | 3.63 Million DKK | 5.74% |
| 2018 Q4 | 3.63 Million DKK | 7.81% |
| 2017 Q3 | 15.98 Million DKK | 10.06% |
| 2017 FY | 3.43 Million DKK | -12.86% |
| 2017 Q2 | 14.52 Million DKK | 6.1% |
| 2017 Q1 | 13.69 Million DKK | 247.42% |
| 2017 Q4 | 3.43 Million DKK | -78.52% |
| 2016 Q1 | 12.43 Million DKK | 208.23% |
| 2016 Q4 | 3.94 Million DKK | -66.15% |
| 2016 FY | 3.94 Million DKK | -2.31% |
| 2016 Q3 | 11.64 Million DKK | -6.53% |
| 2016 Q2 | 12.45 Million DKK | 0.16% |
| 2015 Q1 | - DKK | -100.0% |
| 2015 FY | 4.03 Million DKK | 0.75% |
| 2015 Q4 | 4.03 Million DKK | 0.0% |
| 2015 Q3 | - DKK | 0.0% |
| 2015 Q2 | - DKK | 0.0% |
| 2014 Q2 | - DKK | 0.0% |
| 2014 Q1 | - DKK | -100.0% |
| 2014 FY | 4 Million DKK | 10.33% |
| 2014 Q3 | - DKK | 0.0% |
| 2014 Q4 | 4 Million DKK | 0.0% |
| 2013 Q1 | - DKK | -100.0% |
| 2013 Q4 | 3.62 Million DKK | 0.0% |
| 2013 FY | 3.62 Million DKK | -14.17% |
| 2013 Q2 | -1.00 DKK | -53687091200.0% |
| 2013 Q3 | - DKK | 100.0% |
| 2012 FY | 4.22 Million DKK | 15.58% |
| 2012 Q2 | - DKK | 0.0% |
| 2012 Q4 | 4.22 Million DKK | 0.0% |
| 2012 Q1 | - DKK | -100.0% |
| 2012 Q3 | - DKK | 0.0% |
| 2011 Q2 | - DKK | 0.0% |
| 2011 Q4 | 3.65 Million DKK | 0.0% |
| 2011 Q3 | - DKK | 0.0% |
| 2011 Q1 | - DKK | -100.0% |
| 2011 FY | 3.65 Million DKK | 6.55% |
| 2010 Q4 | 3.43 Million DKK | 1.75% |
| 2010 Q1 | 3.34 Million DKK | 1.49% |
| 2010 FY | 3.43 Million DKK | 4.16% |
| 2010 Q3 | 3.37 Million DKK | -8.12% |
| 2010 Q2 | 3.67 Million DKK | 9.78% |
| 2009 Q4 | 3.29 Million DKK | 0.0% |
| 2009 FY | 3.29 Million DKK | 5.34% |
| 2008 FY | 3.12 Million DKK | 0.0% |
| 2007 FY | - DKK | 0.0% |
| 2006 FY | - DKK | 0.0% |
| 2005 FY | - DKK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -899.208% |
| Arrayit Corporation | 464.19 Thousand USD | -715.826% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | -400.264% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 158884.067% |
| DermTech, Inc. | 1 Million USD | -277.191% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | -14.788% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | -316.461% |
| iMD Companies, Inc. | 38.31 Thousand USD | -9783.6% |
| IDenta Corp. | 442.28 Thousand USD | -756.243% |
| Interpace Biosciences, Inc. | 1.22 Million USD | -208.639% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -2221.39% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | -383.036% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 1009966.667% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | -707.852% |
| PharmChem, Inc. | 391.93 Thousand USD | -866.227% |
| Proteome Sciences plc | 1.06 Million USD | -255.42% |
| Response Genetics, Inc | 133 Thousand USD | -2747.368% |
| Rennova Health, Inc. | 242.64 Thousand USD | -1460.716% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -5024.701% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -3860.427% |
| Todos Medical Ltd. | 1.02 Million USD | -270.911% |